Evidence map›Paper›PMID 11118219›Full record

ArticleThe EMBO journal2000

Srb7p is a physical and physiological target of Tup1p.

A Gromöller, N Lehming

Open access · greenAbstract read
In one paragraph

Article in The EMBO journal, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. TPI and GAPDH Interact with Rad9, Linking Glycolytic Enzymes to Cancer.International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Repression by theeLife · 2021
    Article
  7. Article
  8. Article
  9. Twenty years of Mediator complex structural studies.Biochemical Society transactions · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

A GromöllerMax-Delbrück-Laboratorium in der Max-Planck-Gesellschaft, Carl-von-Linné-Weg 10, 50829 Köln, Germany.
N Lehming

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The holoenzyme of transcription integrates the positive and negative signals from the promoters of eukaryotic genes. We demonstrate that the essential holoenzyme component Srb7p is a physiologically relevant target of the global repressor Tup1p in Saccharomyces cerevisiae. Tup1p binds Srb7p in vivo and in vitro, and all genes tested that are repressed by Tup1p are derepressed when wild-type Srb7p is replaced by a mutant derivative of Srb7p that is no longer capable of interacting with Tup1p. Therefore, Srb7p is the first holoenzyme component essential for repression by Tup1p for which a physical interaction with Tup1p has been demonstrated. Furthermore, we find that Srb7p also binds Med6p and that this interaction is necessary for full transcriptional activation by different activators. Our finding that Med6p and Tup1p compete for the interaction with Srb7p suggests a model for Tup1p-mediated repression.

Indexed as

Drosophila ProteinsNuclear ProteinsSaccharomyces cerevisiae ProteinsTrans-ActivatorsAmino Acid SequenceAnimalsCloning, MolecularDrosophila melanogasterFungal ProteinsHumansMediator ComplexMolecular Sequence DataRecombinant Fusion ProteinsRepressor ProteinsRNA Polymerase IISaccharomyces cerevisiaeDrosophila ProteinsFungal ProteinsMed6 protein, DrosophilaMED6 protein, S cerevisiaeMediator ComplexNuclear ProteinsRecombinant Fusion ProteinsRepressor ProteinsRNA Polymerase IISaccharomyces cerevisiae ProteinsSRB7 protein, S cerevisiaeTrans-ActivatorsTranscription FactorsTUP1 protein, S cerevisiae

Identifiers

PMID11118219
PMCPMC305904
OpenAlexW2029235165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.